Neuroinflammation and Cognitive Impairment Mechanisms

Neuroinflammation denotes the sustained activation of the brain’s innate immune system, chiefly microglial cells and astrocytes, in response to injury, infection or accumulation of misfolded proteins. Although acute inflammatory responses can confer protection and promote tissue repair, chronic activation leads to elevated levels of cytokines, chemokines and reactive oxygen species that disrupt synaptic function and neuronal survival. Central pathways implicated include Toll-like receptor signalling, activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) cascade, and dysregulation of anti-inflammatory mediators such as interleukin-10. In parallel, blood–brain barrier permeability may increase, permitting peripheral immune components or microbial endotoxins to enter the parenchyma and amplify local inflammation. These processes contribute to accumulation and propagation of pathological proteins, including amyloid-β and hyperphosphorylated tau, culminating in synaptic loss, neuronal death and measurable deficits in learning, memory and executive function. Understanding the intricate balance between protective and deleterious inflammatory signals is therefore crucial for devising strategies that preserve cognitive health in ageing and neurodegenerative disorders.

Research from Nature Portfolio

Recent animal models of systemic inflammation have clarified how peripheral immune challenges translate into central effects. In one study, peripheral administration of bacterial lipopolysaccharide (LPS) induced robust microglial activation in the hippocampus, elevated levels of tumour necrosis factor-α, interleukin-1β and prostaglandin E₂, and impaired spatial memory performance in maze and avoidance tasks. Concomitant examination of signalling pathways revealed activation of NF-κB and upregulation of inducible nitric oxide synthase and cyclooxygenase-2. Inhibiting Toll-like receptor 4 (TLR4) prevented these changes and preserved cognitive function, suggesting that modulation of this receptor complex can decouple systemic inflammation from central synaptic deficits. Another line of inquiry has focused on endogenous molecules that attenuate neuroinflammation. Administration of the plant hormone osmotin prior to LPS challenge suppressed TLR4-dependent downstream activation of IKKα/β and NF-κB, reduced release of inflammatory mediators and protected against LPS-induced loss of synaptic proteins such as PSD-95 and SNAP-25. Behavioural assays demonstrated that treated animals retained normal performance in memory and recognition tests, indicating that enhancing anti-inflammatory receptor pathways offers a viable route to preserve cognitive integrity in inflammatory settings.

Neuroinflammation and Cognitive Impairment Mechanisms publication trend

The graph below shows the total number of articles in neuroinflammation and cognitive impairment mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Microglia: Resident immune cells of the central nervous system that mediate innate inflammatory responses.

Lipopolysaccharide (LPS): A component of Gram-negative bacteria that, when present in blood or brain, triggers strong innate immune activation.

Toll-like receptor 4 (TLR4): A pattern-recognition receptor on microglia and other cells that realises LPS and initiates pro-inflammatory signalling.

NF-κB: A transcription factor complex that regulates expression of cytokines, chemokines and enzymes involved in inflammation.

Synaptic proteins (e.g. PSD-95): Structural and signalling components at neuronal synapses critical for transmission and plasticity.

References

1. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Scientific Reports (2019).
2. Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway. Scientific Reports (2016).
3. The endotoxin hypothesis of Alzheimer’s disease. Molecular Neurodegeneration (2024).
4. PSMC5 regulates microglial polarization and activation in LPS-induced cognitive deficits and motor impairments by interacting with TLR4. Journal of Neuroinflammation (2023).